— Know what they know.
Not Investment Advice

ACUS OTC

Acusphere, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: +0.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 48 · $49 mcap · 5M float · 0.0021% daily turnover

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 23 Grade D
Profitability
40
Balance Sheet
48
Earnings Quality
42
Growth
53
Value
23
Momentum
53
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ACUS scores highest in Growth (53/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-29.74
Distress Zone
Piotroski F-Score
2/9
✗ ✗ ✗ ✓ ✗ ✗ ✗ ✗ ✓
Beneish M-Score
-7.02
Unlikely Manipulator
Ohlson O-Score
6.70
Bankruptcy prob: 99.9%
High Risk
Credit Rating
B-
Score: 20.0/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: 0.59x
Accruals: -42.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ACUS scores -29.74, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ACUS scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ACUS's score of -7.02 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ACUS's implied 99.9% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ACUS receives an estimated rating of B- (score: 20.0/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.00x
PEG
-0.00x
P/S
0.00x
P/B
0.00x
P/FCF
-0.58x
P/OCF
—
EV/EBITDA
-0.70x
EV/Revenue
10.24x
EV/EBIT
-0.56x
EV/FCF
-0.91x
Earnings Yield
-286.69%
FCF Yield
-172.35%
Shareholder Yield
3.39%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. ACUS currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
-2.120
NI / EBT
×
Interest Burden
-0.481
EBT / EBIT
×
EBIT Margin
-18.374
EBIT / Rev
×
Asset Turnover
0.056
Rev / Assets
×
Equity Multiplier
3.463
Assets / Equity
=
ROE
-363.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ACUS's ROE of -363.3% is driven by financial leverage (equity multiplier: 3.46x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of -2.12 suggests the company retains less than 60% of pre-tax earnings after taxes.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.00
Median 1Y
$0.00
5th Pctile
$0.00
95th Pctile
$0.00
Ann. Volatility
629.3%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Sherri C. Oberg
President and Chief Executive Officer
$420,799 $— $765,948
John F. Thero
Senior Vice President and Chief Financial Officer
$280,000 $— $569,717
Howard Bernstein, M.D.,
Ph.D. Executive Vice President of Research and Development
$299,000 $— $478,068
Richard Walovitch, Ph.D.
Senior Vice President of Clinical Research
$260,000 $— $338,257
Michael R. Slater
Senior Vice President of Operations
$241,000 $— $327,177

CEO Pay Ratio

7:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $765,948
Avg Employee Cost (SGA/emp): $103,551
Employees: 118

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
118
+1.7% YoY
Revenue / Employee
$22,602
Rev: $2,667,000
Profit / Employee
$-455,339
NI: $-53,730,000
SGA / Employee
$103,551
Avg labor cost proxy
R&D / Employee
$365,890
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'03 Q1'04 Q2'04 Q3'04 Q4'04 Q1'05 Q2'05 Q3'05 Q4'05 Q1'06 Q2'06 Q3'06 Q4'06 Q1'07 Q2'07 Q3'07 Q4'07 Q1'08 Q2'08 Q3'08 Current
ROE -12.4% -28.6% -52.7% -54.3% -60.0% -49.9% -76.8% -71.0% -86.7% -83.0% -96.3% -1.1% -1.1% -1.3% -94.8% -1.3% -1.3% -1.9% -2.1% -3.6% -3.63%
ROA -11.4% -26.3% -46.4% -45.1% -49.5% -40.0% -55.7% -52.0% -56.5% -54.5% -60.0% -65.1% -64.1% -74.7% -57.2% -69.5% -73.2% -85.3% -88.0% -1.0% -1.05%
ROIC 6.4% 6.9% 7.8% 29.5% 7.8% 3.7% 2.4% 1.7% 1.7% 1.8% 2.3% 2.8% 3.0% 3.1% 2.9% 3.5% 3.3% 22.9% 27.9% -45.6% -45.65%
ROCE -11.4% -27.8% -51.6% -52.7% -62.3% -36.6% -55.3% -53.7% -61.9% -82.4% -76.7% -97.9% -85.9% -1.0% -78.2% -1.1% -1.6% -2.0% -4.1% -14.6% -14.63%
Gross Margin — — — 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 1.00%
Operating Margin — — — 7.5% 10.8% 10.0% 19.2% 11.4% 13.3% 14.7% 99.3% 1077.0% 18.5% 18.8% 20.3% 21.2% 18.7% 19.9% 12.6% 29.3% 29.31%
Net Margin — — — -7.4% -10.6% -9.3% -17.9% -11.3% -13.5% -15.7% -93.0% -1061.8% -18.0% -18.8% -22.0% -21.0% -18.8% -20.2% -12.9% -30.3% -30.33%
EBITDA Margin — — — -7.2% -10.3% -9.7% -18.1% -11.3% -9.2% -12.6% -85.8% -929.8% -13.5% -15.9% -15.6% -20.2% -15.7% -17.0% -8.9% -21.9% -21.92%
FCF Margin — — — -29.0% -18.4% -15.5% -14.3% -18.8% -18.6% -17.8% -21.7% -25.3% -27.6% -29.6% -19.3% -15.5% -16.0% -11.8% -11.4% -11.3% -11.27%
OCF Margin — — — -21.0% -11.3% -8.6% -6.4% -9.2% -8.9% -9.9% -16.3% -21.9% -27.0% -29.1% -19.0% -15.2% -15.6% -11.5% -11.2% -11.2% -11.15%
ROA 3Y Avg snapshot only -1.19%
ROIC Economic snapshot only 14.40%
Cash ROA snapshot only -1.24%
NOPAT Margin snapshot only 17.60%
Pretax Margin snapshot only 8.85%
R&D / Revenue snapshot only 14.96%
SGA / Revenue snapshot only 4.41%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q4'03 Q1'04 Q2'04 Q3'04 Q4'04 Q1'05 Q2'05 Q3'05 Q4'05 Q1'06 Q2'06 Q3'06 Q4'06 Q1'07 Q2'07 Q3'07 Q4'07 Q1'08 Q2'08 Q3'08 Current
P/E Ratio -18.64 -8.73 -4.30 -3.67 -3.64 -3.11 -2.20 -2.31 -2.64 -3.06 -1.67 -1.71 -1.23 -1.75 -1.63 -1.30 -0.56 -0.41 -0.64 -0.35 -0.000
P/S Ratio — — — 117.99 63.66 37.48 24.80 28.43 34.32 44.66 34.16 52.75 42.04 66.11 42.05 25.99 11.27 8.35 11.41 6.54 0.000
P/B Ratio 2.31 2.50 2.27 1.99 2.40 1.26 1.40 1.44 2.05 3.47 1.63 2.23 1.28 2.28 1.68 1.90 1.27 2.19 -39.61 -1.60 0.000
P/FCF -26.25 -9.65 -4.47 -4.07 -3.46 -2.42 -1.73 -1.51 -1.85 -2.51 -1.57 -2.09 -1.52 -2.23 -2.18 -1.68 -0.70 -0.71 -1.00 -0.58 -0.580
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -12.17 -5.82 -2.69 -1.96 -2.32 -0.94 -1.08 -1.33 -2.12 -3.12 -1.26 -1.56 -0.72 -1.54 -1.26 -1.10 -0.49 -0.31 -0.82 -0.70 -0.703
EV/Revenue — — — 59.75 39.39 11.19 12.27 16.42 25.63 40.00 22.22 40.31 21.00 50.06 25.70 17.96 8.24 5.38 12.32 10.24 10.243
EV/EBIT -11.54 -5.54 -2.57 -1.87 -2.22 -0.90 -1.03 -1.28 -1.90 -2.73 -1.08 -1.30 -0.60 -1.28 -1.01 -0.91 -0.42 -0.27 -0.69 -0.56 -0.557
EV/FCF -15.07 -5.94 -2.62 -2.06 -2.14 -0.72 -0.86 -0.87 -1.38 -2.25 -1.02 -1.59 -0.76 -1.69 -1.33 -1.16 -0.51 -0.45 -1.08 -0.91 -0.909
Earnings Yield -5.4% -11.4% -23.2% -27.3% -27.5% -32.2% -45.5% -43.2% -37.9% -32.7% -59.9% -58.3% -81.6% -57.2% -61.4% -76.7% -1.8% -2.5% -1.6% -2.9% -2.87%
FCF Yield -3.8% -10.4% -22.4% -24.6% -28.9% -41.3% -57.8% -66.2% -54.1% -39.8% -63.6% -47.9% -65.7% -44.8% -45.9% -59.6% -1.4% -1.4% -1.0% -1.7% -1.72%
EV/Gross Profit snapshot only 10.243
Acquirers Multiple snapshot only 0.557
Shareholder Yield snapshot only 3.39%
Leverage & Solvency
Metric Trend Q4'03 Q1'04 Q2'04 Q3'04 Q4'04 Q1'05 Q2'05 Q3'05 Q4'05 Q1'06 Q2'06 Q3'06 Q4'06 Q1'07 Q2'07 Q3'07 Q4'07 Q1'08 Q2'08 Q3'08 Current
Current Ratio 12.73 11.55 7.61 5.72 3.60 5.24 3.12 3.23 2.46 1.97 2.58 2.12 2.71 2.41 3.11 2.21 1.45 1.21 0.65 0.29 0.290
Quick Ratio 12.73 11.55 7.61 5.72 3.60 5.24 3.12 3.23 2.46 1.97 2.58 2.12 2.71 2.41 3.11 2.21 1.45 1.21 0.65 0.29 0.290
Debt/Equity 0.02 0.02 0.03 0.02 0.08 0.16 0.28 0.28 0.37 0.50 0.41 0.50 0.38 0.47 0.38 0.50 0.76 1.65 -17.75 -1.30 -1.304
Net Debt/Equity -0.98 -0.96 -0.94 -0.98 -0.91 -0.88 -0.71 -0.61 -0.52 -0.36 -0.57 -0.53 -0.64 -0.55 -0.65 -0.59 -0.34 -0.78 — — —
Debt/Assets 0.02 0.02 0.02 0.02 0.06 0.12 0.18 0.19 0.22 0.27 0.24 0.27 0.23 0.27 0.23 0.27 0.35 0.35 0.44 0.59 0.591
Debt/EBITDA -0.18 -0.07 -0.05 -0.04 -0.12 -0.40 -0.44 -0.44 -0.51 -0.50 -0.48 -0.45 -0.43 -0.42 -0.47 -0.42 -0.40 -0.37 -0.34 -0.37 -0.366
Net Debt/EBITDA 9.03 3.64 1.89 1.91 1.43 2.20 1.11 0.97 0.72 0.36 0.68 0.48 0.72 0.49 0.80 0.49 0.18 0.17 -0.06 -0.25 -0.254
Interest Coverage — — — — — — — — — — — — — — — — — — — — —
Equity Multiplier 1.08 1.09 1.14 1.20 1.36 1.35 1.54 1.49 1.67 1.83 1.67 1.84 1.62 1.74 1.64 1.85 2.19 4.72 -40.59 -2.21 -2.207
Cash Ratio snapshot only 0.210
Cash to Debt snapshot only 0.305
FCF to Debt snapshot only -2.114
Defensive Interval snapshot only 30.7 days
Efficiency & Turnover
Metric Trend Q4'03 Q1'04 Q2'04 Q3'04 Q4'04 Q1'05 Q2'05 Q3'05 Q4'05 Q1'06 Q2'06 Q3'06 Q4'06 Q1'07 Q2'07 Q3'07 Q4'07 Q1'08 Q2'08 Q3'08 Current
Asset Turnover 0.00 0.00 0.00 0.01 0.03 0.03 0.05 0.04 0.04 0.04 0.03 0.02 0.02 0.02 0.02 0.03 0.04 0.04 0.05 0.06 0.056
Inventory Turnover — — — — — — — — — — — — — — — — — — — — —
Receivables Turnover — — — — — — — — — 16.72 7.49 — — 7.76 5.35 — — — — — —
Payables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
DSO — — — 0 0 0 0 0 0 22 49 0 0 47 68 0 0 0 0 0 0.0 days
DIO — — — — — — — — — — — — — — — — — — — — —
DPO — — — — — — — — — — — — — — — — — — — — —
Cash Conversion Cycle — — — — — — — — — — — — — — — — — — — — —
Fixed Asset Turnover snapshot only 0.160
Cash Velocity snapshot only 0.615
Capital Intensity snapshot only 9.023
Growth (YoY)
Metric Trend Q4'03 Q1'04 Q2'04 Q3'04 Q4'04 Q1'05 Q2'05 Q3'05 Q4'05 Q1'06 Q2'06 Q3'06 Q4'06 Q1'07 Q2'07 Q3'07 Q4'07 Q1'08 Q2'08 Q3'08 Current
Revenue — — — — — — — 3.0% 100.0% 33.3% -17.8% -42.5% -48.1% -53.6% -28.6% 35.2% 49.8% 67.7% 41.9% -5.2% -5.25%
Net Income — — — — -3.5% -1.3% -82.0% -52.6% -49.0% -61.6% -48.8% -44.0% -36.9% -20.0% 9.9% 12.3% 12.0% 9.1% 1.6% 10.9% 10.91%
EPS — — — — -2.6% -82.1% -46.1% -37.7% -20.4% -25.8% 5.4% 10.5% 1.7% 27.9% 36.7% 45.3% 41.7% 25.5% 15.8% 12.8% 12.81%
FCF — — — — -5.6% -2.2% -1.4% -1.6% -1.0% -53.4% -24.6% 22.7% 22.7% 22.7% 36.6% 17.1% 13.2% 33.0% 16.0% 31.1% 31.06%
EBITDA — — — — -3.9% -1.4% -93.7% -62.0% -42.8% -43.3% -27.6% -20.1% -25.3% -18.0% 16.9% 14.7% 13.6% 12.0% -4.2% 15.2% 15.20%
Op. Income — — — — 3.8% 1.5% 96.3% 61.9% 52.9% 56.9% 42.7% 39.2% 34.9% 24.1% -11.6% -14.2% -15.3% -14.2% -1.4% -11.7% -11.71%
OCF Growth snapshot only 30.26%
Asset Growth snapshot only -66.23%
Equity Growth snapshot only -1.28%
Debt Growth snapshot only -25.48%
Shares Change snapshot only 2.17%
Dividend Growth snapshot only -76.21%
Growth (CAGR)
Metric Trend Q4'03 Q1'04 Q2'04 Q3'04 Q4'04 Q1'05 Q2'05 Q3'05 Q4'05 Q1'06 Q2'06 Q3'06 Q4'06 Q1'07 Q2'07 Q3'07 Q4'07 Q1'08 Q2'08 Q3'08 Current
Revenue 3Y — — — — — — — — — — — — — — — 46.0% 15.9% 1.2% -5.9% -9.7% -9.67%
Revenue 5Y — — — — — — — — — — — — — — — — — — — — —
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — — 46.0% 15.9% 1.2% -5.9% -9.7% -9.67%
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — 1.2% 68.5% 35.3% 24.6% 20.4% 18.6% 7.5% 1.8% 1.78%
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y — — — — — — — — — — — — 17.2% 15.6% 21.8% 3.4% -5.7% -22.5% -29.0% -39.1% -39.08%
Assets 5Y — — — — — — — — — — — — — — — — — — — — —
Equity 3Y — — — — — — — — — — — — 2.4% -1.1% 7.7% -10.5% -19.5% -49.0% — — —
Book Value 3Y — — — — — — — — — — — — -20.6% -28.7% -23.5% -37.0% -41.5% -62.9% — — —
Dividend 3Y — — — — — — — — — — — — -8.1% -24.1% -31.6% -31.3% -28.4% -35.2% -43.2% -54.8% -54.82%
Growth Quality
Metric Trend Q4'03 Q1'04 Q2'04 Q3'04 Q4'04 Q1'05 Q2'05 Q3'05 Q4'05 Q1'06 Q2'06 Q3'06 Q4'06 Q1'07 Q2'07 Q3'07 Q4'07 Q1'08 Q2'08 Q3'08 Current
Revenue Stability — — — — — — — — 1.00 0.92 0.59 0.19 0.42 0.24 0.22 0.22 0.04 0.07 0.31 0.19 0.187
Earnings Stability — — — — — — — — 0.98 1.00 1.00 1.00 0.99 0.98 0.79 0.73 0.84 0.84 0.63 0.41 0.412
Margin Stability — — — — — — — — — — — 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — — — — — 0.80 0.50 0.80 0.82 0.85 0.92 0.96 0.95 0.95 0.96 0.99 0.96 0.956
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend — — — — — — — — -0.39 -0.79 -0.39 -0.72 -0.33 -0.54 -0.22 -0.50 -1.35 -4.16 — — —
Gross Margin Trend — — — — — — — — — — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Margin Trend — — — — — — — — — — — -1.37 -9.14 -13.01 -1.26 6.55 7.08 11.88 9.09 9.11 9.113
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q4'03 Q1'04 Q2'04 Q3'04 Q4'04 Q1'05 Q2'05 Q3'05 Q4'05 Q1'06 Q2'06 Q3'06 Q4'06 Q1'07 Q2'07 Q3'07 Q4'07 Q1'08 Q2'08 Q3'08 Current
OCF/Net Income 0.68 0.82 0.80 0.65 0.64 0.72 0.56 0.75 0.69 0.68 0.80 0.71 0.79 0.77 0.74 0.76 0.78 0.56 0.63 0.59 0.595
FCF/OCF 1.05 1.10 1.21 1.38 1.63 1.79 2.26 2.04 2.07 1.79 1.33 1.15 1.02 1.02 1.02 1.02 1.02 1.03 1.02 1.01 1.011
FCF/Net Income snapshot only 0.601
CapEx/Revenue — — — 8.0% 7.1% 6.8% 8.0% 9.6% 9.6% 7.9% 5.4% 3.4% 61.2% 56.9% 29.0% 34.1% 37.3% 33.7% 23.4% 11.9% 11.87%
CapEx/Depreciation snapshot only 0.031
Accruals Ratio -0.04 -0.05 -0.09 -0.16 -0.18 -0.11 -0.24 -0.13 -0.18 -0.17 -0.12 -0.19 -0.14 -0.17 -0.15 -0.17 -0.16 -0.37 -0.33 -0.43 -0.425
Sloan Accruals snapshot only -1.011
Cash Flow Adequacy snapshot only -32.733
Dividends & Buybacks
Metric Trend Q4'03 Q1'04 Q2'04 Q3'04 Q4'04 Q1'05 Q2'05 Q3'05 Q4'05 Q1'06 Q2'06 Q3'06 Q4'06 Q1'07 Q2'07 Q3'07 Q4'07 Q1'08 Q2'08 Q3'08 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.8% 1.2% 1.3% 2.7% 2.4% 3.2% 2.3% 2.8% 3.3% 7.6% 7.6% 3.4% 3.4% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.41 $0.65 $0.89 $0.94 $0.86 $0.78 $0.62 $0.59 $0.50 $0.49 $0.36 $0.24 $0.12 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — 0 0 0 0 1 1 1 0 0 0 0 0 0 0
Chowder Number — — — — — — — — — — — 2.42 0.70 0.19 -0.08 -0.04 0.03 -0.22 -0.49 -0.72 -0.723
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -37.9% -39.9% -52.0% -63.5% -18.2% -64.1% -72.6% -64.4% -50.6% -11.6% -57.6% -36.4% -82.4% -58.6% -50.4% -61.5% -62.6% -84.3% -0.2% -0.1% -0.06%
Total Shareholder Return -37.9% -39.9% -52.0% -63.5% -18.2% -64.1% -72.6% -63.7% -49.4% -10.2% -54.9% -34.0% -79.2% -56.3% -47.6% -58.2% -55.1% -76.7% 3.2% 3.3% 3.33%
DuPont Factors
Metric Trend Q4'03 Q1'04 Q2'04 Q3'04 Q4'04 Q1'05 Q2'05 Q3'05 Q4'05 Q1'06 Q2'06 Q3'06 Q4'06 Q1'07 Q2'07 Q3'07 Q4'07 Q1'08 Q2'08 Q3'08 Current
Tax Burden (NI/EBT) -1.06 -1.06 -1.03 -1.02 -1.00 -0.96 -0.92 -0.93 -0.96 -1.02 -1.00 -1.00 -0.97 -0.94 -1.03 -1.03 -1.04 -1.40 -1.92 -2.12 -2.120
Interest Burden (EBT/EBIT) -1.02 -0.97 -0.99 -0.99 -0.99 -1.01 -1.03 -1.03 -1.01 -0.98 -0.99 -0.99 -1.01 -1.03 -0.98 -0.98 -0.98 -0.73 -0.53 -0.48 -0.481
EBIT Margin — — — -32.00 -17.75 -12.44 -11.88 -12.84 -13.47 -14.64 -20.63 -31.09 -34.97 -39.13 -25.53 -19.72 -19.76 -20.03 -17.74 -18.37 -18.374
Asset Turnover 0.00 0.00 0.00 0.01 0.03 0.03 0.05 0.04 0.04 0.04 0.03 0.02 0.02 0.02 0.02 0.03 0.04 0.04 0.05 0.06 0.056
Equity Multiplier 1.08 1.09 1.14 1.20 1.21 1.25 1.38 1.36 1.53 1.52 1.60 1.63 1.65 1.79 1.66 1.84 1.79 2.28 2.35 3.46 3.463
Per Share
Metric Trend Q4'03 Q1'04 Q2'04 Q3'04 Q4'04 Q1'05 Q2'05 Q3'05 Q4'05 Q1'06 Q2'06 Q3'06 Q4'06 Q1'07 Q2'07 Q3'07 Q4'07 Q1'08 Q2'08 Q3'08 Current
EPS (Diluted TTM) $-4.71 $-9.56 $-14.87 $-17.08 $-16.83 $-17.41 $-21.72 $-23.51 $-20.25 $-21.89 $-20.55 $-21.05 $-19.91 $-15.78 $-13.01 $-11.51 $-11.61 $-11.76 $-10.95 $-10.03 $-10.03
Book Value/Share $38.04 $33.39 $28.19 $31.46 $25.56 $42.98 $33.98 $37.89 $26.06 $19.29 $21.09 $16.15 $19.05 $12.09 $12.62 $7.88 $5.13 $2.19 $-0.18 $-2.19 $5.57
Tangible Book/Share $38.04 $33.39 $28.19 $31.46 $25.56 $42.98 $33.98 $37.89 $26.06 $19.29 $21.09 $16.15 $19.05 $12.09 $12.62 $7.88 $5.13 $2.19 $-0.18 $-2.19 $-2.19
Revenue/Share $0.00 $0.00 $0.00 $0.53 $0.96 $1.44 $1.92 $1.91 $1.56 $1.50 $1.00 $0.68 $0.58 $0.42 $0.50 $0.58 $0.58 $0.57 $0.61 $0.54 $0.63
FCF/Share $-3.34 $-8.65 $-14.33 $-15.38 $-17.70 $-22.33 $-27.57 $-36.00 $-28.89 $-26.66 $-21.82 $-17.30 $-16.03 $-12.37 $-9.73 $-8.94 $-9.23 $-6.79 $-6.99 $-6.03 $-10.02
OCF/Share $-3.19 $-7.85 $-11.83 $-11.16 $-10.85 $-12.45 $-12.21 $-17.66 $-13.93 $-14.88 $-16.35 $-14.99 $-15.67 $-12.14 $-9.58 $-8.74 $-9.01 $-6.60 $-6.85 $-5.97 $-9.78
Cash/Share $38.17 $32.74 $27.13 $31.59 $25.38 $44.78 $33.77 $33.46 $23.20 $16.54 $20.54 $16.52 $19.47 $12.44 $13.06 $8.55 $5.64 $5.32 $2.57 $0.87 $6.12
EBITDA/Share $-4.14 $-8.82 $-14.00 $-16.19 $-16.32 $-17.22 $-21.76 $-23.67 $-18.83 $-19.20 $-17.64 $-17.67 $-16.94 $-13.60 $-10.31 $-9.40 $-9.71 $-9.81 $-9.19 $-7.80 $-7.80
Debt/Share $0.76 $0.61 $0.74 $0.69 $2.01 $6.83 $9.66 $10.48 $9.68 $9.56 $8.55 $8.01 $7.26 $5.73 $4.82 $3.91 $3.89 $3.61 $3.13 $2.85 $2.85
Net Debt/Share $-37.41 $-32.13 $-26.39 $-30.90 $-23.37 $-37.95 $-24.11 $-22.98 $-13.52 $-6.98 $-11.99 $-8.52 $-12.21 $-6.70 $-8.24 $-4.64 $-1.75 $-1.70 $0.56 $1.98 $1.98
Academic Models
Metric Trend Q4'03 Q1'04 Q2'04 Q3'04 Q4'04 Q1'05 Q2'05 Q3'05 Q4'05 Q1'06 Q2'06 Q3'06 Q4'06 Q1'07 Q2'07 Q3'07 Q4'07 Q1'08 Q2'08 Q3'08 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -29.744
Altman Z-Prime snapshot only -70.029
Piotroski F-Score 2 2 2 2 2 2 2 2 2 2 1 1 2 2 4 5 2 2 2 2 2
Beneish M-Score — — — — — — — -2.97 -3.21 -3.49 -4.36 -24.80 -3.51 -4.52 -2.58 45.43 -3.62 -4.89 -4.91 -7.02 -7.017
Ohlson O-Score snapshot only 6.698
Net-Net WC snapshot only $-5.81
Credit
Metric Trend Q4'03 Q1'04 Q2'04 Q3'04 Q4'04 Q1'05 Q2'05 Q3'05 Q4'05 Q1'06 Q2'06 Q3'06 Q4'06 Q1'07 Q2'07 Q3'07 Q4'07 Q1'08 Q2'08 Q3'08 Current
Credit Rating snapshot only B-
Credit Score 86.54 85.90 85.91 65.44 54.35 54.82 54.16 55.80 54.08 52.67 53.76 54.03 53.56 51.84 51.54 49.80 45.23 43.89 20.00 20.00 20.000
Credit Grade snapshot only 16
Credit Trend snapshot only -29.798
Implied Spread (bps) snapshot only 900.000
Industry Credit Rank snapshot only 23
Sector Credit Rank snapshot only 24

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms